港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

醫藥外包概念

1,656.921

-15.995-0.96%

漲家數：2

跌家數：6

平家數：- -

市盈率：- -

高：1,689.707

開：1,673.364

低：1,646.606

收：1,672.916

資料載入中...

《股市簡訊》中國藥明康德H股勁揚7.2%，一季度淨利同比激增約九成

港股藥明康德(02359.HK)漲超5%，一季度淨利潤36.72億元，同比增長89.06%。

在手訂單攀升，藥明康德2025年業績指引不變

音頻 | 格隆匯4.29盤前要點—港A美股你需要關注的大事都在這

智通港股早知道 | 工信部發布2025年汽車標準化工作要點超前開展飛行汽車等新業態標準化需求研究

港股公告掘金 | 滬上阿姨擬全球發售241.134萬股H股，引入盈峯控股、華置為基石投資者

【財聞聯播】東莞擬出新政：新房實行全裝修銷售！藥明康德一季報出爐

一季報搶先看！藥明康德、興齊眼藥淨利增長，榮昌扭虧趨勢明顯

医药经济报

金斯瑞(01548.HK)斥2.25億美元增持CDMO服務附屬Probio Cayman

阿斯达克财经

復宏漢霖(02696.HK)HLX22單克隆抗體3期臨牀試驗申請德國獲批

阿斯达克财经

藥明康德一季度淨利增長89%，在手訂單增超四成至523億元

藥明康德一季度淨利增近9成在手訂單大幅增長

昭衍新藥(06127.HK)：2025年第一季度歸屬股東淨利潤4111.95萬元，同比實現扭虧為盈。

方達控股一季度收益約5710萬美元同比減少10.6%

昭衍新藥(06127)公佈第一季度業績歸母淨利約4111.95萬元同比扭虧為盈

A股公告精選 | 藥明康德(603259.SH)、中金公司(601995.SH)一季度淨利同比增長

智通财经网

金斯瑞生物科技(01548)擬收購合共3億股Probio Cayman A類優先股

復宏漢霖(02696)：HLX22聯合XELOX一線治療HER2陽性局部晚期或轉移性胃食管交界部和胃癌的國際多中心3期臨牀試驗申請於德國獲批

方達控股(01521)一季度收益約5710萬美元同比減少10.6%

FMR LLC增持藥明康德(02359)152.63萬股每股作價約57.1港元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK1576/news?page=4"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1576","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1576\",,,,,undefined,":{"symbol":"BK1576","market":"HK","secType":"PLATE","nameCN":"醫藥外包概念","latestPrice":1656.921,"timestamp":1746000495720,"preClose":1672.9159,"halted":0,"volume":46989588,"delay":0,"changeRate":-0.009561,"floatShares":0,"shares":0,"eps":0,"marketStatus":"勞動節休市","change":-15.994873,"latestTime":"04-30 16:00:00","open":1673.3644,"high":1689.7068,"low":1646.6055,"amount":1196093850,"amplitude":0.025764,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1746149400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1745976600000,1745985600000],[1745989200000,1746000000000]],"pbRate":1.989191,"peRate":9.524219,"turnoverRate":0.003721,"increases":2,"decrements":6,"flats":0,"marketCap":350848075776,"floatMarketCap":154609044736},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1576\",,,,,undefined,":{"symbol":"BK1576","high":1689.7068,"amplitude":0.025764,"preClose":1672.9159,"low":1646.6055,"pbRate":"1.989191","latestPrice":1656.921,"volume":46989588,"delay":0,"open":1673.3644,"prevYearClose":1395.7731,"prevWeekClose":1649.561,"prevMonthClose":1656.921,"prevQuarterClose":1941.338,"fiveDayClose":1645.051,"twentyDayClose":1942.366,"sixtyDayClose":1438.36,"secType":"PLATE","market":"HK","turnoverRate":0.003721,"peRate":9.524219,"marketCap":350848075776,"floatMarketCap":154609044736,"timestamp":1746000495720,"nameCN":"醫藥外包概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1576\",,,,undefined,":{"bkCode":"BK1576","up":2,"down":6,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1576\",pageSize:20,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2531216538","title":"《股市簡訊》中國藥明康德H股勁揚7.2%，一季度淨利同比激增約九成","url":"https://stock-news.laohu8.com/highlight/detail?id=2531216538","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531216538?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 09:26","pubTimestamp":1745890005,"startTime":"0","endTime":"0","summary":"《股市简讯》中国药明康德H股劲扬7.2%，一季度净利同比激增约九成* 为制药公司代工研发、生产药物的中国药明康德H股2359.HK周二早盘一度劲扬7.2%，其A股603259.SS升约4.4%；公司一季度净利同比激增约九成。* 恒生香港上市生物科技指数.HSHKBIO盘中涨2%。* 药明康德周一公布，一季度净利同比大增近九成，因产能效率提升，以及出售药明合联部分股权等带来投资收益。* 今年迄今药明康德H股累涨7.6%，其A股累升8.7%。更多股市简讯请点选CN-CMN-HOT  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250429:nL4S3R702W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1997245177.USD","LU1997244956.HKD","603259","LU1997245094.SGD","BK1141","BK1583","LU2125910500.SGD","LU2242644610.SGD","LU0052750758.USD","LU0708995583.HKD","LU2045819591.USD","02359","BK1576","BK0216","LU0320764599.SGD","LU1046422090.SGD","LU2488822045.USD","LU2495084118.USD","LU0456842615.SGD"],"gpt_icon":0},{"id":"2531307213","title":"港股藥明康德(02359.HK)漲超5%，一季度淨利潤36.72億元，同比增長89.06%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2531307213","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531307213?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 09:23","pubTimestamp":1745889804,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU1997245177.USD","02359","LU1997245094.SGD","LU0052750758.USD","LU0456842615.SGD","LU2488822045.USD","LU2495084118.USD","LU2125910500.SGD","LU1046422090.SGD","BK4614","YANG","BK1141","BK1576","BK0216","LU0708995583.HKD","LU2045819591.USD","LU2242644610.SGD","HSCEI","07226","LU0320764599.SGD","LU1997244956.HKD","603259","HSTECH","BK1583"],"gpt_icon":0},{"id":"2531479213","title":"在手訂單攀升，藥明康德2025年業績指引不變","url":"https://stock-news.laohu8.com/highlight/detail?id=2531479213","media":"中金在线","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531479213?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 08:53","pubTimestamp":1745887989,"startTime":"0","endTime":"0","summary":"尽管过去几个月外部的环境跌宕起伏,但药明康德2025年一季度的收入与利润均重回双位数增长,超越了外部的预期。药明康德表示,公司目前将维持年初制定的全年业绩指引不变,即预计2025年持续经营业务收入将实现双位数增长,同比提升10%-15%,公司整体收入也将直达415-430亿元。药明康德一向对全年经营情况素来有着精准的预判,即使在2024年充满挑战的时期,全年业绩也稳稳落入了指引区间内。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042909014397493e9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042909014397493e9e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0708995583.HKD","BK1141","BK1576","LU2045819591.USD","LU2242644610.SGD","LU0052750758.USD","LU2125910500.SGD","LU1046422090.SGD","LU0320764599.SGD","02359","BK1583"],"gpt_icon":0},{"id":"2531573290","title":"音頻 | 格隆匯4.29盤前要點—港A美股你需要關注的大事都在這","url":"https://stock-news.laohu8.com/highlight/detail?id=2531573290","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531573290?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 07:35","pubTimestamp":1745883335,"startTime":"0","endTime":"0","summary":"美股小幅震荡，三大指数涨跌不一；ChatGPT杀入电商赛道；突发！西班牙遭遇史上最严重停电；玉渊谭天：一些增量政策6月底前推出，美国如何出牌中方都有准备；赛力斯拟赴港IPO...","market":"sg","thumbnail":"https://img7.gelonghui.com/column/2/109.png?guru_height=540&guru_width=375","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/109.png?guru_height=540&guru_width=375"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/2111722","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1576","LU2242644610.SGD","BK1583","LU0052750758.USD","02359","LU1046422090.SGD","LU0320764599.SGD","LU2045819591.USD","BK1141","LU2125910500.SGD","LU0708995583.HKD"],"gpt_icon":0},{"id":"2531296795","title":"智通港股早知道 | 工信部發布2025年汽車標準化工作要點 超前開展飛行汽車等新業態標準化需求研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2531296795","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531296795?lang=zh_tw&edition=fundamental","pubTime":"2025-04-29 07:25","pubTimestamp":1745882740,"startTime":"0","endTime":"0","summary":"工信部发布2025年汽车标准化工作要点：超前开展飞行汽车等新业态标准化需求研究工信部发布2025年汽车标准化工作要点。其中提出，前瞻布局前沿领域标准研究。分析评估前沿技术发展趋势和潜在应用场景，识别研判未来汽车标准化发展方向，推动制定及发布车用人工智能、固态电池、电动汽车换电等标准子体系，启动数据治理及应用等新领域标准体系建设，超前开展飞行汽车等新业态标准化需求研究。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1287034.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03908","BK1576","LU0052750758.USD","SG9999002828.SGD","HK0000320223.HKD","BK1161","BK1501","06855","02696","HSCEI","LU2045819591.USD","BK1564","BK1147","BK1141","BK1583","LU2242644610.SGD","HSTECH","02359","HK0000306685.HKD","LU2125910500.SGD","BK1574","06127","LU0320764599.SGD","BK4614","LU0708995583.HKD","BK1516","HK0000320264.USD","01548","LU1046422090.SGD","YANG","HK0000306701.USD"],"gpt_icon":1},{"id":"2530235686","title":"港股公告掘金 | 滬上阿姨擬全球發售241.134萬股H股，引入盈峯控股、華置為基石投資者","url":"https://stock-news.laohu8.com/highlight/detail?id=2530235686","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530235686?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 22:58","pubTimestamp":1745852296,"startTime":"0","endTime":"0","summary":"【重大事项】沪上阿姨(02589)拟全球发售241.134万股H股，引入盈峰控股、华置为基石投资者钧达股份(02865)4月28日-5月2日招股，拟全球发行6343.23万股H股金斯瑞生物科技(01548)拟收购合共3亿股Probio Cayman A类优先股亚盛医药-B(06855)五项临床前进展亮相2025年AACR年会，耐立克联合APG-2575展现显著协同效应美的集团(00300)获中国银","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1286874.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02359","HSTECH","LU0052750758.USD","BK1141","YANG","06936","LU2045819591.USD","BK4614","BK1151","LU2125910500.SGD","BK1161","02589","06855","LU2242644610.SGD","02865","BK1583","LU0320764599.SGD","LU0708995583.HKD","BK1574","BK1576","LU1046422090.SGD"],"gpt_icon":1},{"id":"2530849482","title":"【財聞聯播】東莞擬出新政：新房實行全裝修銷售！藥明康德一季報出爐","url":"https://stock-news.laohu8.com/highlight/detail?id=2530849482","media":"券商中国","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530849482?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 22:01","pubTimestamp":1745848868,"startTime":"0","endTime":"0","summary":"宏观动态国家数据局：“东数西算”枢纽节点智算规模超八成据央视新闻，记者28日从国家数据局了解到，我国算力资源布局进一步优化，全国一体化算力网加快构建。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202504283391592795.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0052750758.USD","BK1576","LU2045819591.USD","LU0320764599.SGD","BK1141","LU2242644610.SGD","BK1583","LU0708995583.HKD","LU1046422090.SGD","LU2125910500.SGD","02359"],"gpt_icon":0},{"id":"2530236705","title":"一季報搶先看！藥明康德、興齊眼藥淨利增長，榮昌扭虧趨勢明顯","url":"https://stock-news.laohu8.com/highlight/detail?id=2530236705","media":"医药经济报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530236705?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 21:54","pubTimestamp":1745848456,"startTime":"0","endTime":"0","summary":"药明康德一季报：净利超36亿元今日，药明康德发布2025年第一季度报告，报告期内实现营业收入96.55亿元，同比增长20.96%；归属于上市公司股东的净利润36.72亿元，同比增长89.06%；归属于上市公司股东的扣除非经常性损益的净利润23.29亿元，同比增长14.50%。截至2025年3月末，药明康德持续经营业务在手订单523.3亿元，同比增长47.1%。净利润方面，亏损2.5亿元，扭亏趋势明显。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428232459a6cbdda5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428232459a6cbdda5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603259","LU1046422090.SGD","LU0052750758.USD","LU2045819591.USD","LU2125910500.SGD","BK1141","BK1583","BK1576","LU2242644610.SGD","02359","LU0708995583.HKD","LU0320764599.SGD"],"gpt_icon":0},{"id":"2530286735","title":"金斯瑞(01548.HK)斥2.25億美元增持CDMO服務附屬Probio Cayman","url":"https://stock-news.laohu8.com/highlight/detail?id=2530286735","media":"阿斯达克财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530286735?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 21:43","pubTimestamp":1745847780,"startTime":"0","endTime":"0","summary":"金斯瑞生物科技(01548.HK) 公布关连交易，向MUSM VII及HSUM XIV收购Probio Cayman合共3亿股A类优先股，总代价2.25亿美元(约17亿港元)。完成后，公司持有Probio Cayman权益将由目前71.72%增至85.09%，后者主要为生物科技及制药公司提供全面的合约开发及生产组织(CDMO)服务。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2025-04-28 16:25。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190702162421146_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190702162421146_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1436477/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["HK0000320223.HKD","01548","HK0000306701.USD","BK1583","HK0000320264.USD","HK0000306685.HKD","BK1141","BK1576"],"gpt_icon":0},{"id":"2530728678","title":"復宏漢霖(02696.HK)HLX22單克隆抗體3期臨牀試驗申請德國獲批","url":"https://stock-news.laohu8.com/highlight/detail?id=2530728678","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530728678?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 21:42","pubTimestamp":1745847720,"startTime":"0","endTime":"0","summary":"复宏汉霖(02696.HK) 公布，HLX22(重组人源化抗HER2单克隆抗体注射液)联合曲妥珠单抗和化疗对比曲妥珠单抗和化疗联合或不联合帕博利珠单抗一线治疗HER2阳性局部晚期或转移性胃食管交界部和胃癌的国际多中心3期临床试验申请于德国获批。HLX22为公司许可引进并后续自主研发的新型靶向HER2的单克隆抗体，潜在适应症包括胃癌和乳腺癌等实体瘤。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2025-04-28 16:25。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20191009132907304_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20191009132907304_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1436475/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1576","BK1161","02696","03347","BK1583","BK1141"],"gpt_icon":0},{"id":"2530284596","title":"藥明康德一季度淨利增長89%，在手訂單增超四成至523億元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530284596","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530284596?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 21:34","pubTimestamp":1745847268,"startTime":"0","endTime":"0","summary":"4月28日晚间，无锡药明康德新药开发股份有限公司发布2025年第一季度业绩，期内营业收入为96.5亿元，同比增长21%，其中持续经营业务收入93.9亿元，同比增长23.1%；归母净利润为36.72亿元，同比增长89.06%，归母扣非净利润为20.34亿元，同比增长14.5%。药明康德一季度业绩此次的季度收入也是药明康德时隔8个季度后营收再现表观双位数增长。最新财报显示，截至2025年3月末，药明康德持续经营业务在手订单523.3亿元，同比增长47.1%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504282139369748903f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504282139369748903f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","02359","LU0052750758.USD","LU2045819591.USD","LU2125910500.SGD","BK1141","LU2242644610.SGD","LU0320764599.SGD","BK1583","LU0708995583.HKD","LU1046422090.SGD"],"gpt_icon":0},{"id":"2530528552","title":"藥明康德一季度淨利增近9成 在手訂單大幅增長","url":"https://stock-news.laohu8.com/highlight/detail?id=2530528552","media":"新华财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530528552?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 21:29","pubTimestamp":1745846946,"startTime":"0","endTime":"0","summary":"一季报显示，报告期内公司出售持有的药明合联生物技术有限公司部分股权及处置交割部分业务带来的投资收益约为14.06亿元。一季报还显示，截至2025年3月末，公司持续经营业务在手订单523.3亿元，同比增长 47.1%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042821290997488cc7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042821290997488cc7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","LU0708995583.HKD","LU0052750758.USD","LU0320764599.SGD","BK1576","LU2125910500.SGD","LU2242644610.SGD","LU2045819591.USD","02359","LU1046422090.SGD","BK1583","603259"],"gpt_icon":0},{"id":"2530283833","title":"昭衍新藥(06127.HK)：2025年第一季度歸屬股東淨利潤4111.95萬元，同比實現扭虧為盈。","url":"https://stock-news.laohu8.com/highlight/detail?id=2530283833","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530283833?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 21:18","pubTimestamp":1745846302,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1576","BK0216","603127","BK1141","06127"],"gpt_icon":0},{"id":"2530075264","title":"方達控股一季度收益約5710萬美元 同比減少10.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530075264","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530075264?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 20:48","pubTimestamp":1745844480,"startTime":"0","endTime":"0","summary":"方达控股(01521)发布公告，于截至2025年3月31日止三个月，集团取得亏损净...方达控股(01521)发布公告，于截至2025年3月31日止三个月，集团取得亏损净额约90万美元，而2024年同期则取得亏损净额约100万美元;收益约5710万美元，较2024年同期约6390万美元减少10.6%。经扣除以股份为基础的薪酬开支、并购所得无形资产摊销及并购相关开支后，集团的经调整纯利约为160万美元，而2024年同期则约为220万美元。于2025年3月31日，集团的未经审核综合资产净值约为3.35亿美元，而于2024年12月31日则约为3.34亿美元。追加内容本文作者可以追加内容哦 !","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428205208a46a80f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250428205208a46a80f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1576","01521","BK1141"],"gpt_icon":0},{"id":"2530092405","title":"昭衍新藥(06127)公佈第一季度業績 歸母淨利約4111.95萬元 同比扭虧為盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2530092405","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530092405?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 20:07","pubTimestamp":1745842045,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昭衍新药(06127)公布2025年第一季度业绩，营业收入约2.87亿元，同比减少11.54%;归属于上市公司股东的净利润约4111.95万元，同比扭亏为盈;基本每股收益0.05元。公告称，净利增长主要系上年同期生物资产公允价值变动损失较多所致。受市场环境变化、行业竞争格局调整及客户需求波动等因素综合影响，本报告期新签订单金额约为人民币 4.3 亿，截止本报告期末，在手订单金额约为人民币 22 亿。公司在手订单执行受多种因素的影响，请投资者注意投资风险。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1286659.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","603127","BK1576","BK0216","06127"],"gpt_icon":0},{"id":"2530106401","title":"A股公告精選 | 藥明康德(603259.SH)、中金公司(601995.SH)一季度淨利同比增長","url":"https://stock-news.laohu8.com/highlight/detail?id=2530106401","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530106401?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 20:02","pubTimestamp":1745841767,"startTime":"0","endTime":"0","summary":"湖南白银公告，2025年第一季度营业收入18.9亿元，同比增长19.01%。净利润2798.32万元，同比增长494.88%。","market":"sg","thumbnail":"https://img.zhitongcaijing.com/image/20250428/20250428200318_75770.png?x-oss-process=image/format,jpg/quality,q_60&image_source=0","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20250428/20250428200318_75770.png?x-oss-process=image/format,jpg/quality,q_60&image_source=0"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1286658.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU1997245177.USD","02359","LU0052750758.USD","399300","LU0708995583.HKD","SG9999002828.SGD","BK0216","LU2045819591.USD","601995","BK1516","BK1564","BK1141","603259","BK1576","LU0456842615.SGD","LU1997245094.SGD","BK1147","LU2495084118.USD","LU2488822045.USD","BK1501","LU2242644610.SGD","LU1046422090.SGD","159982","BK1583","03908","LU1997244956.HKD","BK0276","LU0320764599.SGD","LU2125910500.SGD"],"gpt_icon":0},{"id":"2530547494","title":"金斯瑞生物科技(01548)擬收購合共3億股Probio Cayman A類優先股","url":"https://stock-news.laohu8.com/highlight/detail?id=2530547494","media":"智通财经","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530547494?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 19:14","pubTimestamp":1745838848,"startTime":"0","endTime":"0","summary":"于本公告日期，不考虑雇员持股计划股份的未来配发及发行，本公司直接及透过其直接全资附属公司Probio BVI间接拥有Probio Cayman约71.72%。紧接交割前，本公司直接及间接持有Probio Cayman 71.72%。凭藉本集团在多个领域的深厚积淀，Probio Cayman已成长为一家领先的CDMO服务提供商，为抗体开发、蛋白疗法、细胞疗法及基因疗法的创新者赋能。本公司和蓬勃集团多年来一直投资于具有治疗潜力的新分子实体、加速客户的研发项目并保持 Probio Cayman 在技术创新领域的领先地位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1286583.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","HK0000320223.HKD","01548","HK0000306685.HKD","BK1576","BK1583","HK0000320264.USD","HK0000306701.USD"],"gpt_icon":0},{"id":"2530471728","title":"復宏漢霖(02696)：HLX22聯合XELOX一線治療HER2陽性局部晚期或轉移性胃食管交界部和胃癌的國際多中心3期臨牀試驗申請於德國獲批","url":"https://stock-news.laohu8.com/highlight/detail?id=2530471728","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530471728?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 19:01","pubTimestamp":1745838119,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复宏汉霖 公布，近日，HLX22联合曲妥珠单抗和化疗对比曲妥珠单抗和化疗 联合或不联合帕博利珠单抗一线治疗HER2阳性局部晚期或转移性胃食管交界部和胃癌的国际多中心3期临床试验申请于德国获批。公司拟于条件具备后于德国及其他欧盟国家开展临床试验。据悉，HLX22为公司许可引进并后续自主研发的新型靶向HER2的单克隆抗体，潜在适应症包括胃癌和乳腺癌等实体瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1286568.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","BK1583","BK1161","02696","03347","BK1576"],"gpt_icon":0},{"id":"2530475342","title":"方達控股(01521)一季度收益約5710萬美元 同比減少10.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530475342","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530475342?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 18:26","pubTimestamp":1745835987,"startTime":"0","endTime":"0","summary":"智通财经APP讯，方达控股(01521)发布公告，于截至2025年3月31日止三个月，集团取得亏损净额约90万美元，而2024年同期则取得亏损净额约100万美元;收益约5710万美元，较2024年同期约6390万美元减少10.6%。经扣除以股份为基础的薪酬开支、并购所得无形资产摊销及并购相关开支后，集团的经调整纯利约为160万美元，而2024年同期则约为220万美元。于2025年3月31日，集团的未经审核综合资产净值约为3.35亿美元，而于2024年12月31日则约为3.34亿美元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1286519.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","BK1576","01521","BK1583"],"gpt_icon":0},{"id":"2530478670","title":"FMR LLC增持藥明康德(02359)152.63萬股 每股作價約57.1港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530478670","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530478670?lang=zh_tw&edition=fundamental","pubTime":"2025-04-28 18:04","pubTimestamp":1745834669,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，4月23日，FMR LLC增持药明康德(02359)152.63万股，每股作价为57.0986港元，总金额约为8714.96万港元。增持后最新持股数目约为3894.82万股，持股比例为10.06%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1286485.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["603259","BK1576","LU1997245177.USD","LU2495084118.USD","BK1583","LU0320764599.SGD","BK0216","BK1141","LU0052750758.USD","LU1997245094.SGD","LU2125910500.SGD","LU0456842615.SGD","LU0708995583.HKD","LU2045819591.USD","LU2242644610.SGD","LU2488822045.USD","02359","LU1997244956.HKD","LU1046422090.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}]}}